Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q51073096 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000224.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q51073096 | ||
024 | ‡a 0000-0003-2623-094X ‡2 orcid | ||
024 | ‡a 25960350600 ‡2 scopus | ||
035 | ‡a (OCoLC)Q51073096 | ||
100 | 0 | ‡a স্টুয়ার্ট এম রবিনসন ‡9 bn | |
400 | 0 | ‡a Stuart M. Robinson ‡c researcher ‡9 en | |
400 | 0 | ‡a Stuart M Robinson ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury. | ||
670 | ‡a Author's Chronic pancreatitis: Do serum biomarkers provide an association with an inflammageing phenotype? | ||
670 | ‡a Author's Hepatic sinusoidal obstruction syndrome reduces the effect of oxaliplatin in colorectal liver metastases | ||
670 | ‡a Author's Idiopathic pseudomembranous colitis limited to the right colon: a change from Clostridium difficile | ||
670 | ‡a Author's Immunotherapy for treating metastatic colorectal cancer. | ||
670 | ‡a Author's Laparoscopic liver resection: is there a learning curve? | ||
670 | ‡a Author's Laparoscopic Pringle's manoeuvre for liver resection?: how I do it | ||
670 | ‡a Author's Laparoscopic splenic biopsy--porcine to human studies--using a fibrin sealant technique | ||
670 | ‡a Author's Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma | ||
670 | ‡a Author's Methods of haemostasis during liver resection--a UK national survey | ||
670 | ‡a Author's Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. | ||
670 | ‡a Author's Role of nuclear factor kappaB in liver health and disease. | ||
670 | ‡a Author's Strategies to reduce pancreatic stump complications after open or laparoscopic distal pancreatectomy | ||
670 | ‡a Author's Surgical adjuncts to laparoscopic distal pancreatectomy | ||
670 | ‡a Author's The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome | ||
670 | ‡a Author's What to do for the incidental pancreatic cystic lesion? | ||
909 | ‡a (scopus) 25960350600 ‡9 1 | ||
909 | ‡a (orcid) 000000032623094x ‡9 1 | ||
919 | ‡a experimentalstudytoidentifythepotentialroleofpharmacogenomicsindeterminingtheoccurrenceofoxaliplatininducedliverinjury ‡A An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury. ‡9 1 | ||
919 | ‡a whattodofortheincidentalpancreaticcysticlesion ‡A What to do for the incidental pancreatic cystic lesion? ‡9 1 | ||
919 | ‡a potentialcontributionoftumourrelatedfactorstothedevelopmentoffolfoxinducedsinusoidalobstructionsyndrome ‡A The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome ‡9 1 | ||
919 | ‡a surgicaladjunctstolaparoscopicdistalpancreatectomy ‡A Surgical adjuncts to laparoscopic distal pancreatectomy ‡9 1 | ||
919 | ‡a strategiestoreducepancreaticstumpcomplicationsafteropenorlaparoscopicdistalpancreatectomy ‡A Strategies to reduce pancreatic stump complications after open or laparoscopic distal pancreatectomy ‡9 1 | ||
919 | ‡a roleofnuclearfactorkappabinliverhealthanddisease ‡A Role of nuclear factor kappaB in liver health and disease. ‡9 1 | ||
919 | ‡a pathogenesisoffolfoxinducedsinusoidalobstructionsyndromeinamurinechemotherapymodel ‡A Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. ‡9 1 | ||
919 | ‡a methodsofhaemostasisduringliverresectionauknationalsurvey ‡A Methods of haemostasis during liver resection--a UK national survey ‡9 1 | ||
919 | ‡a metastaticlymphnoderatioasanimportantprognosticfactorinpancreaticductaladenocarcinoma ‡A Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma ‡9 1 | ||
919 | ‡a laparoscopicsplenicbiopsyporcinetohumanstudiesusingafibrinsealanttechnique ‡A Laparoscopic splenic biopsy--porcine to human studies--using a fibrin sealant technique ‡9 1 | ||
919 | ‡a laparoscopicpringlesmanoeuvreforliverresectionhow1doit ‡A Laparoscopic Pringle's manoeuvre for liver resection?: how I do it ‡9 1 | ||
919 | ‡a laparoscopicliverresectionistherealearningcurve ‡A Laparoscopic liver resection: is there a learning curve? ‡9 1 | ||
919 | ‡a immunotherapyfortreatingmetastaticcolorectalcancer ‡A Immunotherapy for treating metastatic colorectal cancer. ‡9 1 | ||
919 | ‡a idiopathicpseudomembranouscolitislimitedtotherightcolonachangefromclostridiumdifficile ‡A Idiopathic pseudomembranous colitis limited to the right colon: a change from Clostridium difficile ‡9 1 | ||
919 | ‡a hepaticsinusoidalobstructionsyndromereducestheeffectofoxaliplatinincolorectallivermetastases ‡A Hepatic sinusoidal obstruction syndrome reduces the effect of oxaliplatin in colorectal liver metastases ‡9 1 | ||
919 | ‡a chronicpancreatitisdoserumbiomarkersprovideanassociationwithaninflammageingphenotype ‡A Chronic pancreatitis: Do serum biomarkers provide an association with an inflammageing phenotype? ‡9 1 | ||
996 | ‡2 CAOONL|ncf11340653 | ||
996 | ‡2 NUKAT|n 2010179133 | ||
996 | ‡2 ISNI|000000005259442X | ||
996 | ‡2 CAOONL|ncf10144574 | ||
996 | ‡2 J9U|987007459821105171 | ||
996 | ‡2 SUDOC|274105950 | ||
996 | ‡2 BIBSYS|9028521 | ||
996 | ‡2 ISNI|0000000063307115 | ||
996 | ‡2 NII|DA08198943 | ||
996 | ‡2 CAOONL|ncf10021106 | ||
996 | ‡2 ISNI|0000000073949349 | ||
996 | ‡2 ISNI|0000000384863315 | ||
996 | ‡2 J9U|987007275795805171 | ||
996 | ‡2 BAV|495_249467 | ||
996 | ‡2 NKC|jx20110420012 | ||
996 | ‡2 PLWABN|9810638931005606 | ||
996 | ‡2 LC|n 82259111 | ||
996 | ‡2 LC|n 2002066957 | ||
996 | ‡2 BNF|12493002 | ||
996 | ‡2 ISNI|0000000373815895 | ||
996 | ‡2 LC|n 2007041092 | ||
996 | ‡2 SUDOC|189430656 | ||
996 | ‡2 NLA|000035626389 | ||
996 | ‡2 LC|no 99040262 | ||
996 | ‡2 LC|n 94048388 | ||
996 | ‡2 LC|nr2002045166 | ||
996 | ‡2 LC|n 86866668 | ||
996 | ‡2 NII|DA10568604 | ||
996 | ‡2 NTA|074224549 | ||
996 | ‡2 LC|n 2005046495 | ||
996 | ‡2 NUKAT|n 2016154828 | ||
996 | ‡2 SUDOC|165815310 | ||
996 | ‡2 LC|n 88274884 | ||
996 | ‡2 LC|no2012062623 | ||
996 | ‡2 RERO|A012314658 | ||
996 | ‡2 LC|n 94117300 | ||
996 | ‡2 CAOONL|ncf10033359 | ||
996 | ‡2 LC|n 2006164033 | ||
996 | ‡2 RERO|A017986722 | ||
996 | ‡2 SUDOC|196212650 | ||
996 | ‡2 CAOONL|ncf11576026 | ||
996 | ‡2 ISNI|0000000067842529 | ||
996 | ‡2 ISNI|0000000046628291 | ||
996 | ‡2 BIBSYS|3101242 | ||
996 | ‡2 LC|n 50046570 | ||
996 | ‡2 LC|nr 98015244 | ||
996 | ‡2 J9U|987007453669805171 | ||
996 | ‡2 NLA|000035079869 | ||
996 | ‡2 NLA|000035064336 | ||
996 | ‡2 KRNLK|KAC200814061 | ||
996 | ‡2 RERO|A003752283 | ||
996 | ‡2 LC|no2009004108 | ||
996 | ‡2 LC|no2024107665 | ||
996 | ‡2 NLA|000035690350 | ||
996 | ‡2 NTA|332994090 | ||
996 | ‡2 J9U|987007320532405171 | ||
996 | ‡2 LC|no2021034697 | ||
996 | ‡2 BIBSYS|2098987 | ||
996 | ‡2 NSK|000358650 | ||
996 | ‡2 LC|nb2010033277 | ||
996 | ‡2 DNB|1089327668 | ||
996 | ‡2 LC|n 88274885 | ||
996 | ‡2 ISNI|0000000391676438 | ||
996 | ‡2 NLA|000035351882 | ||
996 | ‡2 NTA|25657989X | ||
996 | ‡2 LC|no 96059563 | ||
996 | ‡2 BIBSYS|90985538 | ||
996 | ‡2 NTA|172390834 | ||
996 | ‡2 LC|no2003027958 | ||
996 | ‡2 ISNI|0000000037043988 | ||
996 | ‡2 LC|no2012086770 | ||
996 | ‡2 BIBSYS|90222950 | ||
996 | ‡2 ISNI|0000000036715287 | ||
996 | ‡2 ISNI|0000000023554306 | ||
996 | ‡2 NTA|227521226 | ||
996 | ‡2 NII|DA01314321 | ||
996 | ‡2 ISNI|0000000120330339 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |